Mercer Global Advisors’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Sell
6,501
-2,128
-25% -$529K ﹤0.01% 1295
2025
Q4
$2.37M Buy
8,629
+509
+6% +$139K ﹤0.01% 1031
2025
Q3
$2.13M Buy
8,120
+5,707
+237% +$1.39M ﹤0.01% 1010
2025
Q2
$528K Buy
2,413
+560
+30% +$120K ﹤0.01% 1547
2025
Q1
$415K Sell
1,853
-256
-12% -$70.6K ﹤0.01% 1577
2024
Q4
$691K Sell
2,109
-1,028
-33% -$324K ﹤0.01% 1275
2024
Q3
$941K Buy
3,137
+626
+25% +$192K ﹤0.01% 1041
2024
Q2
$827K Sell
2,511
-23
-0.9% -$8.13K ﹤0.01% 1058
2024
Q1
$1M Sell
2,534
-260
-9% -$96.2K ﹤0.01% 964
2023
Q4
$984K Buy
2,794
+277
+11% +$98K ﹤0.01% 984
2023
Q3
$944K Sell
2,517
-232
-8% -$89.7K ﹤0.01% 967
2023
Q2
$1.05M Sell
2,749
-62
-2% -$22.1K ﹤0.01% 934
2023
Q1
$974K Buy
2,811
+641
+30% +$187K ﹤0.01% 923
2022
Q4
$511K Sell
2,170
-42
-2% -$9.95K ﹤0.01% 1193
2022
Q3
$544K Sell
2,212
-247
-10% -$75.2K ﹤0.01% 1095
2022
Q2
$744K Sell
2,459
-1,284
-34% -$418K ﹤0.01% 966
2022
Q1
$1.54M Sell
3,743
-405
-10% -$159K 0.01% 733
2021
Q4
$1.95M Buy
4,148
+170
+4% +$73.2K 0.01% 633
2021
Q3
$1.69M Buy
3,978
+1,983
+99% +$836K 0.01% 669
2021
Q2
$716K Buy
1,995
+119
+6% +$39.3K 0.01% 976
2021
Q1
$529K Sell
1,876
-241
-11% -$69K ﹤0.01% 1063
2020
Q4
$600K Buy
2,117
+818
+63% +$230K 0.01% 797
2020
Q3
$357K Buy
1,299
+70
+6% +$18.5K 0.01% 885
2020
Q2
$279K Sell
1,229
-283
-19% -$55.6K 0.01% 875
2020
Q1
$230K Sell
1,512
-3,911
-72% -$602K 0.01% 899
2019
Q4
$815K Sell
5,423
-1,431
-21% -$208K 0.02% 580
2019
Q3
$972K Sell
6,854
-993
-13% -$137K 0.02% 492
2019
Q2
$982K Buy
7,847
+1,477
+23% +$174K 0.03% 465
2019
Q1
$702K Buy
+6,370
New +$663K 0.03% 519

Other funds holding WST